Haviland Kate

CIK 00016630224 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001663022

Recent Transactions

50 trades

Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2026-06-30+32,000→ 32,000 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2026-06-09+19,475→ 19,475 total
Award
Avalyn Pharma Inc.$AVLN
Stock Option (Right to Buy)
2026-04-29+26,978→ 26,978 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−80,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−32,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−80,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−70,400→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−224,410→ 70,729 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−2→ 0 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−70,729→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,125→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−80,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−28,500→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−39,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−591→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-07-17+129,210→ 295,139 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-06-26+36,000→ 36,000 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2025-06-09+23,746→ 23,746 total
Sale
Blueprint Medicines Corp
Common Stock
2025-04-01$85.47/sh−600→ 167,827 total
Sale
Blueprint Medicines Corp
Common Stock
2025-04-01$86.14/sh−598→ 167,229 total
Sale
Blueprint Medicines Corp
Common Stock
2025-04-01$88.59/sh−100→ 165,929 total
Sale
Blueprint Medicines Corp
Common Stock
2025-04-01$87.34/sh−1,200→ 166,029 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−16,151→ 168,427 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-03-01+70,400→ 70,400 total
Award
Blueprint Medicines Corp
Common Stock
2025-03-01+35,200→ 184,578 total
Sale
Blueprint Medicines Corp
Common Stock
2025-01-21$110.24/sh−1,446→ 149,378 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-29$97.76/sh−207→ 150,824 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-29$96.74/sh−1,746→ 151,031 total
Sale
Blueprint Medicines Corp
Common Stock
2024-11-29$95.40/sh−400→ 152,777 total
Award
Bicara Therapeutics Inc.$BCAX
Stock Option (Right to Buy)
2024-09-12+23,746→ 23,746 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-06-17+30,000→ 30,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-07$90.69/sh−12,464→ 153,177 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-01+80,000→ 80,000 total
Award
Blueprint Medicines Corp
Common Stock
2024-03-01+40,000→ 165,641 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-06-27+30,000→ 30,000 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$45.72/sh−6,428→ 125,853 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$44.65/sh−212→ 125,641 total
Award
Blueprint Medicines Corp
Common Stock
2023-03-01+40,000→ 132,281 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-03-01+80,000→ 80,000 total
Purchase
Blueprint Medicines Corp
Common Stock
2022-11-03$43.98/sh+1,100→ 92,281 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2022-06-27+19,000→ 19,000 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-07$56.18/sh−1,048→ 91,181 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-03$60.27/sh−1,719→ 92,229 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-03-01+80,000→ 80,000 total
Award
Blueprint Medicines Corp
Common Stock
2022-03-01+40,000→ 93,948 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-12-13−1,000→ 591 total
Sale
Blueprint Medicines Corp
Common Stock
2021-12-13$98.50/sh−210→ 54,453 total
Sale
Blueprint Medicines Corp
Common Stock
2021-12-13$99.65/sh−285→ 54,663 total
Sale
Blueprint Medicines Corp
Common Stock
2021-12-13$96.78/sh−94→ 53,948 total
Sale
Blueprint Medicines Corp
Common Stock
2021-12-13$97.60/sh−411→ 54,042 total

Companies

Recent Filings

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139

View on SEC.gov